BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

423 related articles for article (PubMed ID: 17900444)

  • 1. Desired qualities and hypothetical contextual use of vaginal microbicides in a diverse sample of US women.
    Olsen ML; Cwiak CA; Koudelka C; Jensen JT
    Contraception; 2007 Oct; 76(4):314-8. PubMed ID: 17900444
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Women's interest in vaginal microbicides.
    Darroch JE; Frost JJ
    Fam Plann Perspect; 1999; 31(1):16-23. PubMed ID: 10029928
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Microbicide preference among young women in California.
    Holt BY; Morwitz VG; Ngo L; Harrison PF; Whaley KJ; Pettifor A; Nguyen AH
    J Womens Health (Larchmt); 2006 Apr; 15(3):281-94. PubMed ID: 16620187
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Challenges to microbicide introduction in South Africa.
    Orner P; Harries J; Cooper D; Moodley J; Hoffman M; Becker J; McGrory E; Dabash R; Bracken H
    Soc Sci Med; 2006 Aug; 63(4):968-78. PubMed ID: 16600447
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Microbicides: a new approach to preventing HIV and other sexually transmitted infections.
    Stone A
    Nat Rev Drug Discov; 2002 Dec; 1(12):977-85. PubMed ID: 12461519
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vaginal microbicides.
    O'Brien RF
    Adolesc Med Clin; 2006 Oct; 17(3):673-85; abstract xi. PubMed ID: 17030285
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dual action microbicides: reappraisal of their roles in contraceptive research.
    Chandran P; Kabir SN
    Reprod Biomed Online; 2010 Jan; 20(1):103-13. PubMed ID: 20158995
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Microbicides: a woman-controlled HIV prevention method in the making.
    Lerner S
    SIECUS Rep; 1994; 22(5):10-3. PubMed ID: 12345598
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Safety and acceptability of cellulose sulfate as a vaginal microbicide in HIV-infected women.
    El-Sadr WM; Mayer KH; Maslankowski L; Hoesley C; Justman J; Gai F; Mauck C; Absalon J; Morrow K; Mâsse B; Soto-Torres L; Kwiecien A
    AIDS; 2006 May; 20(8):1109-16. PubMed ID: 16691061
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Will vaginal microbicides solve the HIV problem in Africa?
    Muula AS
    Croat Med J; 2006 Dec; 47(6):895-8. PubMed ID: 17167863
    [No Abstract]   [Full Text] [Related]  

  • 11. The slow evolution of microbicides for STD/HIV prevention.
    Howes J; Bass M
    J Gend Specif Med; 1999; 2(3):22-3. PubMed ID: 11252848
    [No Abstract]   [Full Text] [Related]  

  • 12. Acceptability of a non-woven device for vaginal drug delivery of microbicides or other active agents.
    Joanis CL; Hart CW
    AIDS Behav; 2010 Jun; 14(3):600-6. PubMed ID: 20049522
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Acceptability of vaginal microbicides among female sex workers in urban Beijing, China].
    Han L; Lv F; Zhang GL; Wu ZL
    Zhonghua Liu Xing Bing Xue Za Zhi; 2009 Feb; 30(2):136-8. PubMed ID: 19565872
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Specific microbicides in the prevention of HIV infection.
    Kelly CG; Shattock RJ
    J Intern Med; 2011 Dec; 270(6):509-19. PubMed ID: 21917029
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recommendations for the development of vaginal microbicides. International Working Group on Vaginal Microbicides.
    AIDS; 1996 Jul; 10(8):1-6. PubMed ID: 8828760
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differentiating normal from abnormal rates of genital epithelial findings in vaginal microbicide trials.
    van de Wijgert JH; Kilmarx PH; Jones HE; Karon JM; Chaikummao S
    Contraception; 2008 Feb; 77(2):122-9. PubMed ID: 18226677
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The impact of microbicides and changes in condom usage on HIV prevalence in men and women.
    Chen FH
    AIDS; 2006 Jul; 20(11):1551-3. PubMed ID: 16847411
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Measurement of microbicide acceptability among U.S. adolescent girls.
    Short MB; Perfect MM; Auslander BA; Devellis RF; Rosenthal SL
    Sex Transm Dis; 2007 Jun; 34(6):362-6. PubMed ID: 17038964
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The acceptability of an investigational vaginal microbicide, PRO 2000 Gel, among women in a phase I clinical trial.
    Morrow K; Rosen R; Richter L; Emans A; Forbes A; Day J; Morar N; Maslankowski L; Profy AT; Kelly C; Abdool Karim SS; Mayer KH
    J Womens Health (Larchmt); 2003 Sep; 12(7):655-66. PubMed ID: 14583106
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preparing for microbicide trials in Rwanda: focus group discussions with Rwandan women and men.
    Veldhuijzen N; Nyinawabega J; Umulisa M; Kankindi B; Geubbels E; Basinga P; Vyankandondera J; Van De Wijgert J
    Cult Health Sex; 2006; 8(5):395-406. PubMed ID: 16923644
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.